Aptamer radioligand conjugate - Aptamer scieneces
Alternative Names: ApRC - Aptamer SciencesLatest Information Update: 17 May 2024
At a glance
- Originator Aptamer Sciences
- Class Antineoplastics; Drug conjugates; Oligonucleotides; Radiopharmaceutical diagnostics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 16 Apr 2024 Early research in Solid tumours in South Korea (unspecified route) prior to April 2024 (Aptamer Sciences, pipeline April 2024)